Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome
- PMID: 28934587
- DOI: 10.1146/annurev-physiol-021317-121454
Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome
Abstract
Aging, the main risk factor for cardiovascular disease (CVD), is becoming progressively more prevalent in our societies. A better understanding of how aging promotes CVD is therefore urgently needed to develop new strategies to reduce disease burden. Atherosclerosis and heart failure contribute significantly to age-associated CVD-related morbimortality. CVD and aging are both accelerated in patients suffering from Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder caused by the prelamin A mutant progerin. Progerin causes extensive atherosclerosis and cardiac electrophysiological alterations that invariably lead to premature aging and death. This review summarizes the main structural and functional alterations to the cardiovascular system during physiological and premature aging and discusses the mechanisms underlying exaggerated CVD and aging induced by prelamin A and progerin. Because both proteins are expressed in normally aging non-HGPS individuals, and most hallmarks of normal aging occur in progeria, research on HGPS can identify mechanisms underlying physiological aging.
Keywords: atherosclerosis; cardiovascular disease; heart failure; prelamin A/lamin A; progerin; vascular calcification.
Similar articles
-
Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?Clin Investig Arterioscler. 2018 May-Jun;30(3):120-132. doi: 10.1016/j.arteri.2017.12.007. Epub 2018 Mar 27. Clin Investig Arterioscler. 2018. PMID: 29602596 Review. English, Spanish.
-
Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.J Proteomics. 2013 Oct 8;91:466-77. doi: 10.1016/j.jprot.2013.08.008. Epub 2013 Aug 20. J Proteomics. 2013. PMID: 23969228
-
Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment.Mech Ageing Dev. 2023 Dec;216:111879. doi: 10.1016/j.mad.2023.111879. Epub 2023 Oct 11. Mech Ageing Dev. 2023. PMID: 37832833
-
Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.Cells. 2021 May 11;10(5):1157. doi: 10.3390/cells10051157. Cells. 2021. PMID: 34064612 Free PMC article. Review.
-
Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.Circulation. 2013 Jun 18;127(24):2442-51. doi: 10.1161/CIRCULATIONAHA.112.000571. Epub 2013 May 20. Circulation. 2013. PMID: 23690466
Cited by
-
Cells in Cardiovascular Disease: Using Diversity to Confront Adversity.Cells. 2020 Sep 29;9(10):2192. doi: 10.3390/cells9102192. Cells. 2020. PMID: 33003290 Free PMC article.
-
Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.Cell Cycle. 2019 Oct;18(19):2495-2508. doi: 10.1080/15384101.2019.1651587. Epub 2019 Aug 14. Cell Cycle. 2019. PMID: 31411525 Free PMC article.
-
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson-Gilford progeria syndrome.Aging Cell. 2020 Jun;19(6):e13147. doi: 10.1111/acel.13147. Epub 2020 Apr 29. Aging Cell. 2020. PMID: 32351002 Free PMC article.
-
Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice.Aging Cell. 2021 Jan;20(1):e13285. doi: 10.1111/acel.13285. Epub 2021 Jan 3. Aging Cell. 2021. PMID: 33393189 Free PMC article.
-
Angiopoietin-2 reverses endothelial cell dysfunction in progeria vasculature.Aging Cell. 2025 Feb;24(2):e14375. doi: 10.1111/acel.14375. Epub 2024 Oct 18. Aging Cell. 2025. PMID: 39422121 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical